- Recent Funding
- Investors
- The Column Group
The Column Group portfolio
The Column Group has 8 portfolio companies on record at Recent Funding, with 4 investments in the last 12 months.
About this page
It is a venture capital firm based in San Francisco, US, founded in 2007. It led 10 of the 17 rounds it joined. Its most recent investment on record is TriGemX Bio's $94M funding round in October 2026, which it led, alongside Viking Global Investors and TCG Crossover. By category, its portfolio leans toward Health and bio (8) and Consumer and social (2). It has co-invested with Samsara Biocapital, Nextech Invest and Lux Capital, most often Samsara Biocapital (6 rounds).
About The Column Group
Fund returns
| Fund | Vintage | Size | Net IRR | TVPI | DPI | As of |
|---|---|---|---|---|---|---|
| The Column Group Fund Opportunity Fund III | 2022 | — | 0.2% | 1.01x | 0.34x | Nov 30, 2025 |
| The Column Group Fund V | 2022 | — | -19.1% | 0.77x | 0.00x | Nov 30, 2025 |
| Column Group IV | 2019 | — | -1.8% | 0.95x | 0.07x | Jun 30, 2025 |
| Column Group III | 2016 | — | 7.7% | 1.25x | 0.78x | Jun 30, 2025 |
| Column Group II | 2014 | — | 7.8% | 2.40x | 1.88x | Jun 30, 2025 |
| The Column Group, L.P. | 2005 | — | 23.4% | 2.10x | 0.79x | Dec 31, 2016 |
What The Column Group invests in
- Health and bio · 8 · 100%
- Consumer and social · 2 · 25%
The Column Group recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| round · $94M · lead | Viking Global Investors, TCG Crossover (lead) | ||
| Series B+ · $73.8M · lead | none named | ||
| Series B+ · $40M | Lux Capital, Regeneron Ventures, RA Capital Management (lead) +1 | ||
| Series B+ · $120M · lead | Lux Capital, Regeneron Ventures, Nextech Invest (lead) | ||
| Series A · $101M · lead | DCVC Bio (lead), Bill & Melinda Gates Foundation, Lux Capital (lead) +1 | ||
| Series B+ · $80M | Samsara Biocapital | ||
| Series A · $68M · lead | Euclidean Capital, Samsara Biocapital, Sanofi Ventures | ||
| Series B+ · $75M | EcoR1 Capital, Mirae Asset Venture Investment, Droia Ventures +6 |
How The Column Group invests
The Column Group portfolio companies
TTriGemX Bio$94Mround · Oct 2026
NNura Bio$73.8MSeries B+ · Jun 2026
AAtavistik Bio$40MSeries B+ · Mar 2026
NNilo Therapeutics$101MSeries A · Oct 2025
AA2 Biotherapeutics$80MSeries B+ · Jan 2025
AAccent Therapeutics$75MSeries B+ · Jan 2024
SSynthekine$100MSeries B+ · Jan 2023
HHexagon Bio$47MSeries A · Sep 2020
| Company | Round with The Column Group | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
round · $94M · lead | $94M | Oct 1, 2026 round |
Health and bio |
Series B+ · $73.8M · lead | $141.8M | Jun 22, 2026 Series B+ |
Health and bio |
Series B+ · $40M | $220M | Mar 5, 2026 Series B+ |
Health and bio |
Series A · $101M · lead | $101M | Oct 8, 2025 Series A |
Health and bio |
Series B+ · $80M | $270.5M | Jan 10, 2025 Series B+ |
Health and bio |
Series B+ · $75M | $178M | Jan 23, 2024 Series B+ |
Health and bio |
Series B+ · $100M · lead | $290M | Jan 6, 2023 Series B+ |
Health and bio |
Series A · $47M · lead | $109M | Oct 23, 2026 Series B+ |
Most frequent co-investors
SSamsara Biocapital6 shared rounds · last Jan 10, 2025
NNextech Invest5 shared rounds · last Mar 5, 2026
LLux Capital4 shared rounds · last Mar 5, 2026
EEcoR1 Capital3 shared rounds · last Jan 23, 2024
TTCG Crossover2 shared rounds · last Oct 1, 2026
RRA Capital Management2 shared rounds · last Mar 5, 2026
RRegeneron Ventures2 shared rounds · last Mar 5, 2026
- EEuclidean Capital2 shared rounds · last Sep 18, 2024
GGV2 shared rounds · last Jan 23, 2024
DDroia Ventures2 shared rounds · last Jan 23, 2024
NNS Investment2 shared rounds · last Jan 23, 2024
TThe Mark Foundation for Cancer Research2 shared rounds · last Jan 23, 2024
Similar investors
DDuquesne Family Office8 companies · 4 deals in 12 mo
NNRW.BANK8 companies · 4 deals in 12 mo
TTransformation Capital8 companies · 4 deals in 12 mo
AAsabys Partners8 companies · 3 deals in 12 mo
MModi Ventures8 companies · 3 deals in 12 mo
UUK Innovation & Science Seed Fund8 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Net returns as reported by the public-pension and foundation LPs invested in each fund.
Firm profile and fund returns: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 17 rounds on Recent Funding that name The Column Group. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists The Column Group, which is a subset of its real portfolio. API: /api/v1/investors/the-column-group (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy